收藏切换
Prospects for histone deacetylase inhibitors as antidepressants
收藏切换
PDF
Kai-yun YAO, Hong-wan DING, Lin-yu CAO, Yin-ge GAO, Jian-jun ZHANG, Gui-bin WANG*
Acta Pharmaceutica Sinica | 2021, 56(1) : 29 - 36
Less
收藏切换
Acta Pharmaceutica Sinica | 2021, 56(1): 29-36
Reviews
Prospects for histone deacetylase inhibitors as antidepressants
Full
Kai-yun YAO, Hong-wan DING, Lin-yu CAO, Yin-ge GAO, Jian-jun ZHANG, Gui-bin WANG*
Affiliations
  • Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
Published: 2021-01-12 doi: 10.16438/j.0513-4870.2020-1217
Outline
收藏切换

Depression is a serious mental illness with a high incidence. At present, we do not fully understand the specific pathological mechanisms of depression, and the efficacy of drug treatments is very limited. Recent studies have shown that epigenetic changes that occur in specific brain regions may be a key mechanism by which environmental factors to interact with individuals to influence the risk of depression. Therefore, drugs that target epigenetic regulation may become a new direction for the development of antidepressants. Histone deacetylase inhibitors (HDACi) are a class of compounds that inhibit histone deacetylase activity, which has been reported to be associated with depression; this article addresses the use of HDACi in preclinical studies, and their potential therapeutic role and limitations of use in depression.

histone deacetylase inhibitor  /  depression  /  epigenomics  /  acetylation
Kai-yun YAO, Hong-wan DING, Lin-yu CAO, Yin-ge GAO, Jian-jun ZHANG, Gui-bin WANG. Prospects for histone deacetylase inhibitors as antidepressants[J]. Acta Pharmaceutica Sinica, 2021 , 56 (1) : 29 -36 . DOI: 10.16438/j.0513-4870.2020-1217
Year 2021 volume 56 Issue 1
PDF
176
69
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2020-1217
  • Receive Date:2020-07-20
  • Online Date:2025-12-18
  • Published:2021-01-12
Article Data
Affiliations
History
  • Received:2020-07-20
  • Revised:2020-08-09
Funding
Affiliations
    Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2020-1217
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT